Experience with the GORE EXCLUDER iliac branch endoprosthesis for common iliac artery aneurysms

Steven M.M. Van Sterkenburg; Jan M.M. Heyligers; Mathijs van Bladel; Hence J. Verhagen; Daniël Eefting; Marc R. van Sambeek; Clark J. Zeebregts; Michel M.P.J. Reijnen; Dutch IBE Collaboration

doi:10.1016/j.jvs.2016.01.021

Experience with the GORE EXCLUDER iliac branch endoprosthesis for common iliac artery aneurysms

Steven M.M. Van Sterkenburg^*
, Jan M.M. Heyligers
, Mathijs van Bladel
, Hence J. Verhagen
, Daniël Eefting
, Marc R. van Sambeek
, Clark J. Zeebregts
, Michel M.P.J. Reijnen
, Dutch IBE Collaboration

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

100 Downloads (Pure)

Abstract

Objective: In this study, we analyzed the procedural success and early outcome of endovascular treatment of a multicenter cohort of patients with common iliac artery (CIA) aneurysms treated with the new GORE EXCLUDER (W. L. Gore & Associates, Flagstaff, Ariz) iliac branch endoprosthesis (IBE).

Methods: A retrospective cohort analysis was performed in 13 sites in The Netherlands. Anatomic, demographic, procedural, and follow-up data were assessed from hospital records.

Results: From November 2013 to December 2014, 51 CIA aneurysms were treated with an IBE in 46 patients. The median diameter of the treated aneurysm was 40.5 (range, 25.0-90.0) mm. The mean procedural time was 198 ± 56 minutes. All but one implantation were successful; two type Ib endoleaks were noticed, resulting in a procedural success rate of 93.5%. The two type Ib endoleaks spontaneously disappeared at 30 days. There was no 30-day mortality. Ipsilateral buttock claudication was present in only two cases at 30 days and disappeared during follow-up. The incidence of reported erectile dysfunction was low and severe ischemic complications were absent. After a mean follow-up of 6 months, data on 17 treated aneurysms were available. Two showed a stable diameter, whereas 15 showed a mean decrease of 3.9 ± 2.2 mm (P <.001). Reinterventions were performed in two patients (7.1%). The 6-month primary patency of the internal component of the IBE device was 94%.

Conclusions: The use of the GORE EXCLUDER IBE device for CIA aneurysms is related to high procedural success, high patency rates, and low reintervention rates at short-term follow-up. Prospective data with longer follow-up are awaited to establish the role of the device in the treatment algorithm of CIA aneurysms.

Original language	English
Pages (from-to)	1451-1457
Number of pages	7
Journal	Journal of vascular surgery
Volume	63
Issue number	6
DOIs	https://doi.org/10.1016/j.jvs.2016.01.021
Publication status	Published - 1 Jun 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

n/a OA procedure

Access to Document

10.1016/j.jvs.2016.01.021Licence: Elsevier licence

Cite this

Van Sterkenburg, S. M. M., Heyligers, J. M. M., van Bladel, M., Verhagen, H. J., Eefting, D., van Sambeek, M. R., Zeebregts, C. J., Reijnen, M. M. P. J., & Dutch IBE Collaboration (2016). Experience with the GORE EXCLUDER iliac branch endoprosthesis for common iliac artery aneurysms. Journal of vascular surgery, 63(6), 1451-1457. https://doi.org/10.1016/j.jvs.2016.01.021

@article{e58e3977405640158f268a0f793f24f2,

title = "Experience with the GORE EXCLUDER iliac branch endoprosthesis for common iliac artery aneurysms",

abstract = "Objective: In this study, we analyzed the procedural success and early outcome of endovascular treatment of a multicenter cohort of patients with common iliac artery (CIA) aneurysms treated with the new GORE EXCLUDER (W. L. Gore \& Associates, Flagstaff, Ariz) iliac branch endoprosthesis (IBE).Methods: A retrospective cohort analysis was performed in 13 sites in The Netherlands. Anatomic, demographic, procedural, and follow-up data were assessed from hospital records.Results: From November 2013 to December 2014, 51 CIA aneurysms were treated with an IBE in 46 patients. The median diameter of the treated aneurysm was 40.5 (range, 25.0-90.0) mm. The mean procedural time was 198 ± 56 minutes. All but one implantation were successful; two type Ib endoleaks were noticed, resulting in a procedural success rate of 93.5\%. The two type Ib endoleaks spontaneously disappeared at 30 days. There was no 30-day mortality. Ipsilateral buttock claudication was present in only two cases at 30 days and disappeared during follow-up. The incidence of reported erectile dysfunction was low and severe ischemic complications were absent. After a mean follow-up of 6 months, data on 17 treated aneurysms were available. Two showed a stable diameter, whereas 15 showed a mean decrease of 3.9 ± 2.2 mm (P <.001). Reinterventions were performed in two patients (7.1\%). The 6-month primary patency of the internal component of the IBE device was 94\%.Conclusions: The use of the GORE EXCLUDER IBE device for CIA aneurysms is related to high procedural success, high patency rates, and low reintervention rates at short-term follow-up. Prospective data with longer follow-up are awaited to establish the role of the device in the treatment algorithm of CIA aneurysms.",

keywords = "n/a OA procedure",

author = "\{Van Sterkenburg\}, \{Steven M.M.\} and Heyligers, \{Jan M.M.\} and \{van Bladel\}, Mathijs and Verhagen, \{Hence J.\} and Dani{\"e}l Eefting and \{van Sambeek\}, \{Marc R.\} and Zeebregts, \{Clark J.\} and Reijnen, \{Michel M.P.J.\} and J. Avontuur and T. Smits and \{van Sambeek\}, M.R. and \{van Tongeren\}, R.B.M. and H.J. Verhagen and G. Akkersdijk and D. Eefting and O.R.M. Wikkeling and C.J.J.M. Sikkink and \{Van Bladel\}, M. and S. Holewijn and E. Mathijssen and T. Ko{\"e}ter and \{van Brussel\}, J. and I.F.J. Tielliu and \{Dutch IBE Collaboration\}",

year = "2016",

month = jun,

day = "1",

doi = "10.1016/j.jvs.2016.01.021",

language = "English",

volume = "63",

pages = "1451--1457",

journal = "Journal of vascular surgery",

issn = "0741-5214",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Experience with the GORE EXCLUDER iliac branch endoprosthesis for common iliac artery aneurysms

AU - Van Sterkenburg, Steven M.M.

AU - Heyligers, Jan M.M.

AU - van Bladel, Mathijs

AU - Verhagen, Hence J.

AU - Eefting, Daniël

AU - van Sambeek, Marc R.

AU - Zeebregts, Clark J.

AU - Reijnen, Michel M.P.J.

AU - Avontuur, J.

AU - Smits, T.

AU - van Sambeek, M.R.

AU - van Tongeren, R.B.M.

AU - Verhagen, H.J.

AU - Akkersdijk, G.

AU - Eefting, D.

AU - Wikkeling, O.R.M.

AU - Sikkink, C.J.J.M.

AU - Van Bladel, M.

AU - Holewijn, S.

AU - Mathijssen, E.

AU - Koëter, T.

AU - van Brussel, J.

AU - Tielliu, I.F.J.

AU - Dutch IBE Collaboration

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Objective: In this study, we analyzed the procedural success and early outcome of endovascular treatment of a multicenter cohort of patients with common iliac artery (CIA) aneurysms treated with the new GORE EXCLUDER (W. L. Gore & Associates, Flagstaff, Ariz) iliac branch endoprosthesis (IBE).Methods: A retrospective cohort analysis was performed in 13 sites in The Netherlands. Anatomic, demographic, procedural, and follow-up data were assessed from hospital records.Results: From November 2013 to December 2014, 51 CIA aneurysms were treated with an IBE in 46 patients. The median diameter of the treated aneurysm was 40.5 (range, 25.0-90.0) mm. The mean procedural time was 198 ± 56 minutes. All but one implantation were successful; two type Ib endoleaks were noticed, resulting in a procedural success rate of 93.5%. The two type Ib endoleaks spontaneously disappeared at 30 days. There was no 30-day mortality. Ipsilateral buttock claudication was present in only two cases at 30 days and disappeared during follow-up. The incidence of reported erectile dysfunction was low and severe ischemic complications were absent. After a mean follow-up of 6 months, data on 17 treated aneurysms were available. Two showed a stable diameter, whereas 15 showed a mean decrease of 3.9 ± 2.2 mm (P <.001). Reinterventions were performed in two patients (7.1%). The 6-month primary patency of the internal component of the IBE device was 94%.Conclusions: The use of the GORE EXCLUDER IBE device for CIA aneurysms is related to high procedural success, high patency rates, and low reintervention rates at short-term follow-up. Prospective data with longer follow-up are awaited to establish the role of the device in the treatment algorithm of CIA aneurysms.

AB - Objective: In this study, we analyzed the procedural success and early outcome of endovascular treatment of a multicenter cohort of patients with common iliac artery (CIA) aneurysms treated with the new GORE EXCLUDER (W. L. Gore & Associates, Flagstaff, Ariz) iliac branch endoprosthesis (IBE).Methods: A retrospective cohort analysis was performed in 13 sites in The Netherlands. Anatomic, demographic, procedural, and follow-up data were assessed from hospital records.Results: From November 2013 to December 2014, 51 CIA aneurysms were treated with an IBE in 46 patients. The median diameter of the treated aneurysm was 40.5 (range, 25.0-90.0) mm. The mean procedural time was 198 ± 56 minutes. All but one implantation were successful; two type Ib endoleaks were noticed, resulting in a procedural success rate of 93.5%. The two type Ib endoleaks spontaneously disappeared at 30 days. There was no 30-day mortality. Ipsilateral buttock claudication was present in only two cases at 30 days and disappeared during follow-up. The incidence of reported erectile dysfunction was low and severe ischemic complications were absent. After a mean follow-up of 6 months, data on 17 treated aneurysms were available. Two showed a stable diameter, whereas 15 showed a mean decrease of 3.9 ± 2.2 mm (P <.001). Reinterventions were performed in two patients (7.1%). The 6-month primary patency of the internal component of the IBE device was 94%.Conclusions: The use of the GORE EXCLUDER IBE device for CIA aneurysms is related to high procedural success, high patency rates, and low reintervention rates at short-term follow-up. Prospective data with longer follow-up are awaited to establish the role of the device in the treatment algorithm of CIA aneurysms.

KW - n/a OA procedure

UR - https://www.scopus.com/pages/publications/84973160669

U2 - 10.1016/j.jvs.2016.01.021

DO - 10.1016/j.jvs.2016.01.021

M3 - Article

C2 - 27230243

AN - SCOPUS:84973160669

SN - 0741-5214

VL - 63

SP - 1451

EP - 1457

JO - Journal of vascular surgery

JF - Journal of vascular surgery

IS - 6

ER -

Experience with the GORE EXCLUDER iliac branch endoprosthesis for common iliac artery aneurysms

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this